BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8503051)

  • 1. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
    Blakely RD; Moore KR; Qian Y
    Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
    [No Abstract]   [Full Text] [Related]  

  • 2. Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs.
    Moore KR; Blakely RD
    Biotechniques; 1994 Jul; 17(1):130-5, 137. PubMed ID: 7946295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
    Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
    J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
    Barker EL; Blakely RD
    Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
    Barker EL; Blakely RD
    Mol Pharmacol; 1996 Oct; 50(4):957-65. PubMed ID: 8863842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aminetransporters].
    Shimada S
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):244-52. PubMed ID: 9162958
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C.
    Jess U; El Far O; Kirsch J; Betz H
    Biochem Biophys Res Commun; 2002 Jun; 294(2):272-9. PubMed ID: 12051706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenatal cocaine exposure on serotonin and norepinephrine transporter density in the rat brain.
    McReynolds AM; Meyer JS
    Ann N Y Acad Sci; 1998 Jun; 846():412-4. PubMed ID: 9668438
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamine reuptake and storage. Overview.
    Bönisch H; Eiden L
    Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
    [No Abstract]   [Full Text] [Related]  

  • 10. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter transporters: recent progress.
    Amara SG; Kuhar MJ
    Annu Rev Neurosci; 1993; 16():73-93. PubMed ID: 8096377
    [No Abstract]   [Full Text] [Related]  

  • 12. An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism.
    Stephan MM; Chen MA; Penado KM; Rudnick G
    Biochemistry; 1997 Feb; 36(6):1322-8. PubMed ID: 9063880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and transporter binding properties of 2,3-diphenyltropane stereoisomers. Comparison to 3beta-phenyltropane-2beta-carboxylic acid esters.
    Chang AC; Burgess JP; Mascarella SW; Abraham P; Kuhar MJ; Carroll FI
    J Med Chem; 1997 Apr; 40(8):1247-51. PubMed ID: 9111298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters.
    Daws LC; Toney GM; Gerhardt GA; Frazer A
    J Pharmacol Exp Ther; 1998 Aug; 286(2):967-76. PubMed ID: 9694957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
    Kocabas AM; Rudnick G; Kilic F
    J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A creatine transporter cDNA from Torpedo illustrates structure/function relationships in the GABA/noradrenaline transporter family.
    Guimbal C; Kilimann MW
    J Mol Biol; 1994 Aug; 241(2):317-24. PubMed ID: 8057375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
    J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transporters.
    Roman DL; Saldaña SN; Nichols DE; Carroll FI; Barker EL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):679-87. PubMed ID: 14593087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.